IGF::OT::IGF Follow-up and Extended Follow-up of Participants - Option 1
$6,590,883N01FY2019CANIH
Fundacion Inciensa, San Jose
Investigators
Abstract
This SOW describes activities related to NCI?s Human Papillomavirus (HPV) vaccine evaluation efforts required for the next phase of these studies and will cover the follow-up of participants in both the existing trial of the bivalent HPV vaccine (Costa Rica Vaccine Trial or CVT) and the new trial aimed at evaluating the non-inferiority of 1 versus 2 doses of the HPV vaccines. Task A and Task B will run concurrently.
View original record on NIH RePORTER →